Skip to content

Characteristics of exhaled breath components in airway diseases

Characteristics of exhaled breath components in airway diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400093574
Enrollment
Unknown
Registered
2024-12-09
Start date
2024-12-09
Completion date
Unknown
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, chronic obstructive pulmonary disease

Interventions

COPD group :None
Control:None

Sponsors

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria for asthmatic patients: (1) age 20-80 years; (2) paroxysmal wheezing, chest tightness, or cough; (3) Positive bronchial provocation test or bronchial dilation test of pulmonary function test; (4) those who signed the informed consent form. 2. Inclusion criteria of COPD patients: (1) age 20-80 years old; (2) wheezing, chest tightness and shortness of breath after activity; (3) history of smoking; (4) The results of pulmonary function test showed obstructive pulmonary ventilation dysfunction, and the bronchial dilation test was negative. (5) those who signed the informed consent form. 3. Inclusion criteria of controls: (1) age 20-80 years old; (2) No obvious lesions were found during physical examination due to pulmonary nodules or other reasons; (3) no symptoms of chest tightness or wheezing; (4) normal pulmonary function, negative bronchial provocation or dilation test; (5) those who signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Exclusion criteria for asthmatic patients: (1) combined with other respiratory diseases (such as bronchiectasis, lung cancer, interstitial lung disease, pneumonia, etc.); (2) diseases with abnormal immune function (such as systemic lupus erythematosus, AIDS, etc.); (3) patients with metabolic diseases (such as diabetes mellitus), liver diseases (such as cirrhosis), kidney diseases (such as uremia), and untreated chronic gastric ulcer with Helicobacter pylori infection; (4) Pregnancy. 2. Exclusion criteria of COPD patients: (1) complicated with other respiratory diseases (such as bronchiectasis, lung cancer, interstitial lung disease, pneumonia, etc.); (2) diseases with abnormal immune function (such as systemic lupus erythematosus, AIDS, etc.); (3) patients with metabolic diseases (such as diabetes mellitus), liver diseases (such as cirrhosis), kidney diseases (such as uremia), and untreated chronic gastric ulcer with Helicobacter pylori infection; (4) Pregnancy. 3. Exclusion criteria of controls: (1) patients with other respiratory diseases (such as asthma, COPD, bronchiectasis, respiratory tract infection, lung cancer, interstitial lung disease, pneumonia, etc.); (2) diseases with abnormal immune function (such as systemic lupus erythematosus, AIDS, etc.); (3) patients with metabolic diseases (such as diabetes mellitus), liver diseases (such as cirrhosis), kidney diseases (such as uremia), and untreated chronic gastric ulcer with Helicobacter pylori infection; (4) Pregnancy.

Design outcomes

Primary

MeasureTime frame
Pulmonary function + provocation test/relaxation test;Exhaled nitric oxide;Blood routine examination;Total IgE;CT Scan of the Lungs;Detection of allergens;ACT scores;CAT scores;

Countries

China

Contacts

Public ContactGuohua Zhen

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

ghzhen@tjh.tjmu.edu.cn+86 135 1727 7794

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026